Huang et al. used the Q11 peptide (section 2) in their development ofa self-assembling adjuvant-free peptide system for cancer immunotherapy.122 They targeted the overexpression of MUC1 proteinsby epithelial cancer cells. This evidence concerns the gene MUC1 and cancer.